Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Chinese Patent Office
US Department of Justice
McKesson
Accenture
Deloitte
Mallinckrodt
Cantor Fitzgerald

Generated: December 19, 2018

DrugPatentWatch Database Preview

Innogenix Company Profile

« Back to Dashboard

What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?

INNOGENIX has four approved drugs.



Summary for Innogenix
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Innogenix

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Innogenix LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075215-002 Jul 29, 1999 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 078953-001 Apr 15, 2010 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 076963-001 Dec 22, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 076963-002 Feb 27, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075215-001 Jul 29, 1999 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix METRONIDAZOLE metronidazole TABLET;ORAL 070772-001 Jul 16, 1986 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Citi
Federal Trade Commission
Medtronic
McKinsey
QuintilesIMS
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.